CIBC World Market
RIGL icon

CIBC World Market’s Rigel Pharmaceuticals RIGL Stock Holding History

CIBC World Market’s Portfolio RIGL Stock Details RIGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-10,825
Closed -$307K – 1527
2025
Q3 		$307K Buy
+10,825
New +$324K ﹤0.01% 1226

Other funds holding RIGL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

CIBC World Market's RIGL Position: Q4 2025 in Review

CIBC World Market sold out of Rigel Pharmaceuticals (RIGL) in Q4 2025, closing a stake of 10,825 shares — an estimated $307K sold.

CIBC World Market first reported a position in RIGL in Q3 2025 and held it in 1 quarter. The position peaked at $307K in Q3 2025. 193 funds tracked by Wall St. Rank hold RIGL as of Q4 2025.

  • CIBC World Market reported no remaining Rigel Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • CIBC World Market sold 10,825 Rigel Pharmaceuticals shares in Q4 2025, an estimated $307K.
  • CIBC World Market first reported a position in Rigel Pharmaceuticals in Q3 2025 and held it in 1 quarter.
  • CIBC World Market's Rigel Pharmaceuticals position peaked at $307K in Q3 2025.
  • 193 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q4 2025.

Based on CIBC World Market's 13F filing for Q4 2025, filed 10 Feb 2026.